We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-14.82%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$930M
AUM Growth
-$317M
Cap. Flow
-$249M
Cap. Flow %
-26.76%
Top 10 Hldgs %
21.4%
Holding
253
New
29
Increased
42
Reduced
84
Closed
45

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.7%
2 Technology 16.24%
3 Healthcare 14.99%
4 Industrials 10.9%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRMW
151
DELISTED
Primo Water Corporation
PRMW
$1.5M 0.16%
107,259
-27,062
-20% -$414K
ANET icon
152
Arista Networks
ANET
$238B
$1.5M 0.16%
113,760
-30,768
-21% -$442K
SRI icon
153
Stoneridge
SRI
$209M
$1.44M 0.16%
58,530
-828
-1% -$21K
CLVS
154
DELISTED
Clovis Oncology, Inc.
CLVS
$1.41M 0.15%
+78,737
New +$1.61M
ESTC icon
155
Elastic
ESTC
$7.81B
$1.41M 0.15%
+19,703
New +$1.33M
GWPH
156
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.36M 0.15%
+13,983
New +$1.83M
TER icon
157
Teradyne
TER
$59.4B
$1.36M 0.15%
43,252
-52,687
-55% -$1.79M
OEC icon
158
Orion
OEC
$410M
$1.35M 0.15%
53,455
-1,524
-3% -$39.8K
ULTA icon
159
Ulta Beauty
ULTA
$24.1B
$1.27M 0.14%
5,198
+237
+5% +$65.5K
DATA
160
DELISTED
Tableau Software, Inc.
DATA
$1.24M 0.13%
10,292
-3,406
-25% -$381K
FOE
161
DELISTED
Ferro Corporation
FOE
$1.22M 0.13%
77,634
-158,717
-67% -$2.9M
VC icon
162
Visteon
VC
$2.78B
$1.2M 0.13%
19,842
-61,000
-75% -$4.6M
GWRE icon
163
Guidewire Software
GWRE
$14.2B
$1.14M 0.12%
14,210
-5,084
-26% -$443K
AAPL icon
164
Apple
AAPL
$4.55T
$1.13M 0.12%
28,708
-27,216
-49% -$1.32M
CLAR icon
165
Clarus
CLAR
$143M
$1.08M 0.12%
106,894
+42,408
+66% +$444K
EGIO
166
DELISTED
Edgio, Inc. Common Stock
EGIO
$604K 0.06%
6,457
-10,400
-62% -$1.52M
NFLX icon
167
Netflix
NFLX
$309B
$558K 0.06%
20,850
-8,730
-30% -$261K
VRTX icon
168
Vertex Pharmaceuticals
VRTX
$125B
$452K 0.05%
2,725
+149
+6% +$25.8K
GBT
169
DELISTED
Global Blood Therapeutics, Inc.
GBT
$403K 0.04%
9,807
-95,316
-91% -$3.57M
ESPR
170
DELISTED
Esperion Therapeutics
ESPR
$384K 0.04%
8,353
-65,718
-89% -$3.17M
AEO icon
171
American Eagle Outfitters
AEO
$3B
-472,837
Closed -$11.7M
ALGN icon
172
Align Technology
ALGN
$12.2B
-22,050
Closed -$8.63M
ANAB icon
173
AnaptysBio
ANAB
$1.67B
-29,897
Closed -$2.98M
BAC icon
174
Bank of America
BAC
$441B
-122,881
Closed -$3.62M
BL icon
175
BlackLine
BL
$1.73B
-60,166
Closed -$3.4M

Similar funds

Nicholas Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Nicholas Investment Partners held 253 positions worth $930M, down 25% from $1.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $249M in Q4 2018, closing 45 positions and reducing 84 holdings. Its most notable exit was American Eagle Outfitters, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Keurig Dr Pepper worth $8.95M.

  • Nicholas Investment Partners's largest Q4 2018 buy was Keurig Dr Pepper: 349,015 shares worth $8.95M.
  • Nicholas Investment Partners added most to Everbridge, Inc. Common Stock in Q4 2018, an estimated $4.91M increase.
  • Nicholas Investment Partners's biggest Q4 2018 reduction was Las Vegas Sands, cutting an estimated $16.3M.
  • Nicholas Investment Partners fully exited American Eagle Outfitters in Q4 2018, selling an estimated $11.7M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $930M portfolio in Q4 2018.
  • Nicholas Investment Partners opened 29 new positions and closed 45 in Q4 2018.
  • Nicholas Investment Partners's portfolio value fell 25% quarter-over-quarter to $930M.

Based on Nicholas Investment Partners's 13F filing for Q4 2018, filed 14 Feb 2019.